Brief: PCI Biotech: Final Confirmation Of Successful Safety Read-Out In Phase I Extension Study
April 8 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* PCI BIOTECH: FINAL CONFIRMATION OF SUCCESSFUL SAFETY
READ-OUT IN
THE PHASE I EXTENSION STUDY
* PCI BIOTECH - FORMAL REVIEW CONFIRMS CO'S PRELIMINARY
REPORT
THAT NO ADVERSE REACTIONS HAVE BEEN REPORTED
* POST-STUDY FOLLOW-UP OF PATIENTS IS ONGOING
Source text for Eikon: ID:nGNE8HqVgB
Further company coverage: PCIB.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process